Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Copyright 2023 – Finance News Network
Source: Finance News Network
22 Mar 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow provides an update on the company's trials.
Read More11 Jun 2020 - Brickworks Limited (ASX:BKW) Managing Director, Lindsay Partridge talks the company's expectations for growth in building materials, its property and investment portfolio in light of COVID-19 and how its diversified portfolio is its strength in times of uncertainty.
Read More06 Aug 2024 - Alderan Resources Limited (ASX:AD8) Managing Director Scott Caithness discusses the company's exploration targets and progress.
Read More15 Jan 2021 - Famed investor, author and market analyst Jim Rogers discusses the impact of the COVID-19 vaccine rollout, Chinese wine stocks, the bond bubble, why he is bullish on commodities, allegations of currency manipulation and how Aussie investors can get ahead.
Read More01 May 2020 - Acorn Capital, Head of Portfolio Implementation and Portfolio manager (Healthcare and Biotechnology sectors) Paul Palumbo looks the microcap sector and the recent market sell off and discusses the outlook for next 6 months and longer term.
Read More18 Jan 2021 - Tourism Accommodation Australia CEO Michael Johnson discusses the impact of COVID-19 on hotels across Australia.
Read More31 Jan 2020 - Los Cerros Limited (ASX:LCL) Managing Director, Jason Stirbinskis, talks about the company's gold projects in Colombia, the potential for high grade porphyry despots and plans to advance drilling at its Chuscal target.
Read More15 Apr 2020 - MLC Senior Economist Bob Cunneen discusses the ongoing impact of the coronavirus on markets including central bank and government measures.
Read More21 Jul 2021 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane provides an update for the June quarter 2021.
Read More29 07 2024 - Neil McIntyre - CEO - Diatreme Resources (ASX:DRX) is an emerging Australian producer of mineral and silica sands based in Brisbane. Our key projects comprise the Northern Silica Project and Galalar Silica Sand Project in Far North Queensland, located next to the world's biggest silica sand mine at Cape Flattery.
Read More
